Clinical Trial Update: Apatinib with Oxaliplatin and S-1 Treatment for Advanced Hepatoid Adenocarcinoma of the Stomach [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating apatinib with oxaliplatin and S-1 for advanced gastric cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Apatinib (apatinib)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Peking University | Conditions: Gastric Cancer | Phase 2 | Status: WITHDRAWN